KEROS THERAPEUTICS INC (KROS) Stock Balance Sheet
NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 720.54M | 559.93M | 331.15M | 279.00M | 230.00M | |||
| Receivables | 17.29M | 2.74M | 143.00K | 0.00 | 18.20M | |||
| Other Current Assets | 21.68M | 26.22M | 16.00M | 6.70M | 3.20M | |||
| Total Current Assets | 759.51M | 588.89M | 347.29M | 285.80M | 251.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 23.14M | 23.49M | 19.47M | 17.60M | 2.40M | |||
| Other Non-Current Assets | 1.91M | 3.50M | 3.26M | 3.40M | 1.40M | |||
| Total Non-Current Assets | 25.05M | 26.99M | 22.73M | 21.00M | 3.90M | |||
| TOTAL ASSETS | 784.56M | 615.89M | 370.02M | 306.80M | 255.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 18.86M | 22.43M | 18.26M | 12.50M | 8.00M | |||
| Accounts Payable | 6.64M | 4.60M | 5.45M | 3.30M | 3.60M | |||
| Other Current Liabilities | 13.88M | 416.00K | 665.00K | 700.00K | 200.00K | |||
| Total Current Liabilities | 39.38M | 27.45M | 24.37M | 16.50M | 11.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 16.31M | 16.88M | 13.44M | 12.80M | 200.00K | |||
| Total Non-Current Liabilities | 16.31M | 16.88M | 13.44M | 12.90M | 300.00K | |||
| TOTAL LIABILITIES | 55.69M | 44.33M | 37.81M | 29.40M | 12.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -420.33M | -568.78M | -381.43M | -228.40M | -123.80M | |||
| Additional Paid In Capital | 1.15B | 1.14B | 713.64M | 505.90M | 366.90M | |||
| Common Shares | 4.00K | 4.00K | 3.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 40.56M | 40.55M | 31.84M | 27.50M | 24.00M | |||
| Tangible Book Value per Share | 17.97 | 14.09 | 10.43 | 10.09 | 10.13 | |||
| Total Shareholders' Equity | 728.87M | 571.55M | 332.21M | 277.40M | 243.20M | |||
| TOTAL LIABILITIES AND EQUITY | 784.56M | 615.89M | 370.02M | 306.80M | 255.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 19.29 | 21.45 | 14.25 | 17.32 | 21.31 | |||
| Return On Assets (ROA) | 0.54% | -30.42% | -41.35% | -34.12% | -23.01% | |||
| Return On Equity (ROE) | 0.58% | -32.78% | -46.05% | -37.74% | -24.15% | |||
All data in USD , ROIC based on taxRate of 0.21